Filtered By:
Management: Centers for Disease Control and Prevention (CDC)
This page shows you your search results in order of date. This is page number 8.
Order by Relevance | Date
Total 2726 results found since Jan 2013.
President Joe Biden Announces COVID-19 National Emergencies Will End on May 11
WASHINGTON — President Joe Biden informed Congress on Monday that he will end the twin national emergencies for addressing COVID-19 on May 11, as most of the world has returned closer to normalcy nearly three years after they were first declared.
The move to end the national emergency and public health emergency declarations would formally restructure the federal coronavirus response to treat the virus as an endemic threat to public health that can be managed through agencies’ normal authorities.
Read More: COVID-19 Is No Longer a Public Health Emergency
It comes as lawmakers have already ended elements of the ...
Source: TIME: Health - January 31, 2023 Category: Consumer Health News Authors: Zeke Miller and Amanda Seitz / AP Tags: Uncategorized COVID-19 overnight wire Source Type: news
The U.S. Still Doesn ’ t Have Good COVID-19 Data. Here ’ s Why That ’ s a Problem
Check the COVID-19 Data Tracker from the U.S. Centers for Disease Control and Prevention (CDC), and you’ll get a rundown of the latest case numbers, hospitalizations, and deaths. Those categories might seem straightforward, but the data, say many experts, are telling us a lot less than we think they are.
That’s because it’s getting increasingly difficult to parse who is hospitalized or dies from COVID-19, and who is hospitalized or dies from another reason but with COVID-19. Across the U.S., “COVID-19 hospitalizations” represent all kinds of patients: those who need hospital-level care for sev...
Source: TIME: Health - January 30, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
Second Phase of the NIH Preprint Pilot Launched
Today, we are pleased to announce the launch of the second phase of the NIH Preprint Pilot with the addition of more than 700 new preprint records to PubMed Central (PMC) and PubMed. This second phase expands the scope of the Pilot to include preprints resulting from all NIH-funded research. Eligible preprints are those acknowledging direct support of an NIH award or authored by NIH staff and posted to bioRxiv, medRxiv, arXiv, or Research Square, on or after January 1, 2023. NLM will automatically include the full text of the preprint (as license terms allow) and associated citation information in PMC and PubMed, respectiv...
Source: PubMed Central News - January 30, 2023 Category: Databases & Libraries Source Type: news
CDC urges people with weak immune systems to take extra precautions after Covid subvariants knock out Evusheld
Children are seen outside a coronavirus disease (COVID-19) testing site in Brooklyn, New York, January 12, 2022. The Centers for Disease Control and Prevention on Friday urged people with weak immune systems to take extra precautions to avoid Covid after the dominant omicron subvariants knocked…#brooklyn #cdc #evusheld #fda #xbb #bq #molnupiravir
Source: Reuters: Health - January 28, 2023 Category: Consumer Health News Source Type: news
FDA Experts Vote to Make All COVID-19 Vaccines and Boosters Bivalent
In a unanimous decision, all 21 voting members of the U.S. Food and Drug Administration’s (FDA) vaccine committee recommended that the U.S. start using the same COVID-19 virus strain in all of the COVID-19 vaccines, including primary and booster doses.
That means the bivalent booster dose, which targets both the original SARS-CoV-2 strain and the Omicron BA.4/5 strains, would soon become the only type used for all primary shots and boosters.
The decision reflects a turning point in the pandemic. Until now, vaccine makers have tried to keep up with constantly evolving variants, but they’ve always been a few step...
Source: TIME: Health - January 27, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
What ’s next for COVID-19 vaccines? Scientists and regulators chart a course amid uncertainty
Just over 2 years ago, the first COVID-19 vaccines arrived—and a roller coaster ride of hope and science began. It soon became clear that although the vaccines protected against severe disease, their ability to fend off infection was limited and faded fast. Meanwhile, SARS-CoV-2 began to evolve rapidly to elude immunity. By now, many people have had four or five vaccine doses, including an updated booster tailored to Omicron strains that was introduced last fall.
Now, regulators and scientists are debating the near-term future. How often will we need booster doses and who should receive them? Should vaccines continu...
Source: Science of Aging Knowledge Environment - January 25, 2023 Category: Geriatrics Source Type: research
CDC figuring out 'logistical and legal' aspects of testing airplane wastewater for coronavirus variants, source says
The US Centers for Disease Control and Prevention is ironing out the "logistical and legal" aspects of testing wastewater from airplanes for coronavirus variants as it continues to explore such a Covid-19 monitoring program.
Source: CNN.com - Health - January 25, 2023 Category: Consumer Health News Source Type: news
The Dose- and Time-Dependent Effectiveness and Safety Associated with COVID-19 Vaccination During Pregnancy: A Systematic Review and Meta-analysis
From December 30, 2019, to May 14, 2022, 517,648,631 people were infected with coronavirus disease 2019 (COVID-19), and 6,261,708 people died in total. The male-to-female ratio was 0.9 among infected people and 1.29 in deceased people [1]. According to the U.S. Centers for Disease Control and Prevention (CDC, https://www.cdc.gov/, last accessed 05/09/22), 207,793 pregnant women in the United States were infected, and 296 died.
Source: International Journal of Infectious Diseases - January 24, 2023 Category: Infectious Diseases Authors: Shengyu Wu, Luyao Wang, Jiaqi Dong, Yirong Bao, Xiaohui Liu, Yuhong Li, Xiaohua Liu, Han Xie, Hao Ying Source Type: research
Syphilis in Dermatology: Recognition and Management
AbstractThe incidence of syphilis has been increasing in the USA since 2000. Notably, the coronavirus disease 2019 pandemic negatively impacted the public health efforts to contain the spread of sexually transmitted diseases including syphilis and congenital syphilis. Clinical manifestations of syphilis are predominantly mucocutaneous lesions, thus dermatologists are primed to recognize the myriad presentations of this disease. Primary syphilis is classically characterized by a painless transient chancre most often located in the genital area. Secondary syphilis typically manifests clinically as systemic symptoms in additi...
Source: American Journal of Clinical Dermatology - January 23, 2023 Category: Dermatology Source Type: research
Safety and Efficacy of Coronavirus Disease 2019 (COVID-19) mRNA Vaccines During Lactation
Obstet Gynecol. 2023 Jan 9. doi: 10.1097/AOG.0000000000005093. Online ahead of print.ABSTRACTIn this review, we summarize the data on the safety and side-effect profile of coronavirus disease 2019 (COVID-19) vaccines during lactation to date, review what is known about mRNA vaccine components in breast milk, and discuss the efficacy of COVID-19 vaccines in providing immune protection for the breastfeeding infant. The Centers for Disease Control and Prevention and the American College of Obstetricians and Gynecologists recommend that lactating individuals receive COVID-19 mRNA vaccines and stay up to date on booster doses, ...
Source: Obstetrics and Gynecology - January 17, 2023 Category: OBGYN Authors: Lydia L Shook Andrea G Edlow Source Type: research
Coronavirus Disease 2019 (COVID-19) Vaccination in Pregnancy
Obstet Gynecol. 2023 Jan 17. doi: 10.1097/AOG.0000000000005100. Online ahead of print.ABSTRACTSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in pregnancy is associated with significant maternal morbidity and mortality, and its risks can be mitigated with coronavirus disease 2019 (COVID-19) vaccination. Vaccination against COVID-19 in pregnancy results in protection against both maternal and neonatal SARS-CoV-2 infection, as well as maternal critical illness. Vaccination during pregnancy is safe, with no documented risks of pregnancy loss, preterm delivery, congenital anomalies, or other adverse peri...
Source: Obstetrics and Gynecology - January 17, 2023 Category: OBGYN Authors: Malavika Prabhu Laura E Riley Source Type: research
Safety and Efficacy of Coronavirus Disease 2019 (COVID-19) mRNA Vaccines During Lactation
Obstet Gynecol. 2023 Jan 10. doi: 10.1097/AOG.0000000000005093. Online ahead of print.ABSTRACTIn this review, we summarize the data on the safety and side-effect profile of coronavirus disease 2019 (COVID-19) vaccines during lactation to date, review what is known about mRNA vaccine components in breast milk, and discuss the efficacy of COVID-19 vaccines in providing immune protection for the breastfeeding infant. The Centers for Disease Control and Prevention and the American College of Obstetricians and Gynecologists recommend that lactating individuals receive COVID-19 mRNA vaccines and stay up to date on booster doses,...
Source: Obstetrics and Gynecology - January 17, 2023 Category: OBGYN Authors: Lydia L Shook Andrea G Edlow Source Type: research
Coronavirus Disease 2019 (COVID-19) Vaccination in Pregnancy
Obstet Gynecol. 2023 Jan 17. doi: 10.1097/AOG.0000000000005100. Online ahead of print.ABSTRACTSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in pregnancy is associated with significant maternal morbidity and mortality, and its risks can be mitigated with coronavirus disease 2019 (COVID-19) vaccination. Vaccination against COVID-19 in pregnancy results in protection against both maternal and neonatal SARS-CoV-2 infection, as well as maternal critical illness. Vaccination during pregnancy is safe, with no documented risks of pregnancy loss, preterm delivery, congenital anomalies, or other adverse peri...
Source: Obstetrics and Gynecology - January 17, 2023 Category: OBGYN Authors: Malavika Prabhu Laura E Riley Source Type: research
